U.S. stock futures fell as investors rebalanced portfolios ahead of the end of a grueling first half and awaited a gauge of inflation that Fed officials consider their preferred measure of prices
Updated June 30, 2022 6:39 am ETU.S. stock futures fell as investors rebalanced portfolios ahead of the end of a grueling first half and awaited a gauge of inflation that Federal Reserve officials consider their preferred measure of rising prices.
Futures tied to the S&P 500 dropped 1.4%, a day after indexes finished little changed. Dow Jones Industrial Average futures fell 1.1% while technology-heavy Nasdaq-100 futures lost 1.7%.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
5 Things to Know Before the Stock Market Opens TuesdayHere are the most important news items that investors need to start their trading day.
Lire la suite »
Coinbase Stock Slapped With Sell Rating by Goldman Sachs | CoinMarketCapAnalysts suggest that further layoffs may be needed to help the exchange bring costs down to a manageable level, as Goldman Sachs has categorized Coinbase stock as a sell rating 👀
Lire la suite »
Polestar’s lukewarm stock debut sends a troubling signal to EV makersThe lukewarm reception for Polestar, the latest electric-vehicle company to go public in the U.S., is sending an ominous message to other startups: The purg
Lire la suite »
Nike stock dives as Wall Street jeers margin outlook rather than cheering profit and revenue beatsShares of Nike took a tumble Tuesday toward a two-year low after multiple Wall Street analysts cut their price targets, as the sporting apparel giant’s disappointing gross margin guidance offset fiscal fourth-quarter profit and revenue beats.
Lire la suite »
Bank of America clients sold last week’s stock-market rally while buying ETFsBank of America clients sold the stock-market rally last week but were buying exchange-traded funds across styles in a tough year for equities, according to...
Lire la suite »
Kezar Life Sciences (KZR) Stock Price: Lots of optimism surrounds lupus trial resultsKezar Life Sciences (KZR) announced a breakthrough late Monday that today concerning a drug to treat lupus nephritis. Results from the second phase cl
Lire la suite »